Urinary Malondialdehyde as a Biomarker of Type 2 Diabetes Mellitus Treatment in the Primary Care Unit of a Tertiary Care Hospital

• Váldodahkkit: Thitiworn Choosong (Dahkki), Rattanaporn Chootong (Dahkki), Supinya Sono (Dahkki), Yupa Noofong (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SAGE Publishing, 2021-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Introduction/Objectives The examination of Urinary Malondialdehyde (UMDA) as a biomarker in the involvement of inflammatory response and oxidative stress, as a mechanism underlying the development of diabetes; in addition to complications in followed-up patients at a primary healthcare unit. The lev...